• 제목/요약/키워드: marine natural compounds

검색결과 148건 처리시간 0.026초

Bioactive Metabolites from Selected Sponges of Korean and Tropical Waters

  • Shin, Jong-Heon;Park, Jung-Rae;Seo, Young-Wan;Lee, Hyi-Seung;Cho, Ki-Woong
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2001년도 Proceedings of the Pharmaceutical Society of Korea
    • /
    • pp.90-94
    • /
    • 2001
  • Wondonins A and B, aromatic alkaloids of an unprecedented skeletal class have been isolated form and association of the sponges Poecillastra wondoensis and Jaspis sp. In addition, four novel bromotyrosine-derived metabolites, psammaplins $A_1$ and $A_2$, aplysinellins A and B, have been isolated from the tropical sponge Aplysinella rhax. The structures of these compounds have been determined on the basis of combined chemical and spectral analyses. The new compounds exhibited significant cytotoxicity and antiangiogenic activity as well as inhibitory activities against farnesyl protein transferase and leucine aminopeptidase. In addition to these compounds, several bioactive metabolites have been isolated from sponges of Korean and tropical waters.

  • PDF

Bioactive Marine Natural Products

  • Son, Byeng-Wha
    • 생약학회지
    • /
    • 제21권1호
    • /
    • pp.1-48
    • /
    • 1990
  • Marine organisms have proven to be rich sources of interesting organic molecules. A great number of compounds with diverse structural features and interesting biological activities have been isolated. Recent studies on secondary metabolites of marine organisms are discussed with a focus on a variety of biological activities and marine natural product literatures are also reviewed.

  • PDF

New Polyene Macrolide Antibiotics from Streptomyces sp. M90025

  • Seo, Young-Wan;Cho, Ki-Woong;Lee, Hyi-Seung;Yoon, Tae-Mi;Shin, Jong-Heon
    • Journal of Microbiology and Biotechnology
    • /
    • 제10권2호
    • /
    • pp.176-180
    • /
    • 2000
  • Three polyene macrolide antibiotics including two new compounds were isolated from the culture mycelia of a Streptomyces species. The structures of these metabollites were determined as elizabethin, a previously reported 28-membered macrolide and two analohs, using combined spectroscopic methods. These compounds exhibited antifungal activity and cytotoxicity against a juman leukemia cell.

  • PDF

Bioactive Marine Natural Products in Drug Development

  • Kim, Se-Kwon;Ravichandran, Y. Dominic;Kim, Moon-Moo;Jung, Won-Kyo
    • 한국해양바이오학회지
    • /
    • 제2권4호
    • /
    • pp.209-223
    • /
    • 2007
  • Nature is one of the most important sources of pharmacologically active compounds in the search for drugs against life threatening diseases. Even though plants and terrestrial microorganisms have played as an important source for the new drug candidates from nature, marine organisms such as tunicates, sponges, soft corals, sea horses, sea snakes, marine mollusks, seaweeds, nudibranches, sea slugs and marine microorganisms are increasingly attracting attention in recent years. Marine organisms also have the potential to develop into future drugs against important diseases, such as cancer, a range of bacterial and viral diseases, malaria, and inflammations. Even though the mechanism of action in the molecular level of most metabolites is still unclear, the mechanisms by which they interfere with the pathogenesis of a wide range of diseases have been reported. The knowledge of this is one of the key factors necessary to develop bioactive compounds into medicines. This is due to their structurally unique and pharmacologically active compounds. The potential pharmaceutical, medicinal and research applications of some of these compounds are discussed in hundreds of scientific papers, and are reviewed here.

  • PDF

Marine Bioprocess Engineering: Building Bridges from Discovery to Commercialization of Marine Natural Products

  • Zhang, Wei;Jin, Meifeng;Yu, Xinju;Deng, Maicun;Yuan, Quan
    • 한국생물공학회:학술대회논문집
    • /
    • 한국생물공학회 2000년도 추계학술발표대회 및 bio-venture fair
    • /
    • pp.137-140
    • /
    • 2000
  • Numerous novel marine natural products have been discovered and isolated from varied marine organisms by the diligent bio-prospectors over the past decades. An assessment of the current status of commercial development of these natural compounds indicates only minimal commercialization due to the lack of sustainable supply. To bridge the gaps between discovery and commercialization of these tantalizing bioactive compounds, marine bioprocess engineering is the key for its success. The problems, challenges and opportunities for marine bioprocess engineers are examined for the timely transformation of the discovery into commercial reality. Marine bioprocess engineers will find it the most rewarding practice of their expertise in diving into the ocean.

  • PDF

Purification and Structure Determination of Antifungal Phospholipids from a Marine Streptomyces

  • Cho, Ki-Woong;Seo, Young-Wan;Yoon, Tae-Mi;Shin, Jong-Heon
    • Journal of Microbiology and Biotechnology
    • /
    • 제9권6호
    • /
    • pp.709-715
    • /
    • 1999
  • A series of antifungal compounds were obtained from the methanol extract of the mycelium from marine actinomycetes M428 which was identified as a Stereptomyces species by fatty acid composition and biochemical characteristics. These compounds were purified by combined chromatographic techniques and the structures were characterized with spectroscopic methods including 1D and 2D NMR, and mass spectrometry as sn-l lysophosphatidyl inositols. The side chains were established by chemical degradation followed by GC analysis to be 14-methyl pentadecanoic acid (iso-palmitic acid, i-C16:0, compound A) and 13-methyl tetradecanoic acid (iso-pentadecanoic acid, i-C15:0, compound B). These compounds displayed highly selective antifungal activity against C. albicans with MIC values of $5{\;}\mu\textrm{g}/ml$ (compound A) and $2.5{\;}\mu\textrm{g}/ml$ (compound B), while it had almost negligible antibiotic activity against E. coli and P aerogenosa with MIC value higher than $50{\;}\mu\textrm{g}/ml$ and no cytotoxic activities against human myeloma leukemia K562 ($IC_{50}>100{\;}\mu\textrm{g}/ml$).

  • PDF

Bioactive Natural Products from Chinese Tropical Marine Plants and Invertebrates

  • Guo, Y.W.;Huang, X.C.;Zhang, W.;Sun, Y.Q.
    • 한국해양바이오학회지
    • /
    • 제1권1호
    • /
    • pp.22-33
    • /
    • 2006
  • This paper deals mainly with chemical and biological investigations, recently effected in the authors' laboratory, of Chinese tropical marine plants and invertebrates on three topics: 1) an unusual macrocyclic polydisulfide from the Chinese mangrove Bruguiera gymnorrhiza; 2) polyhydroxylpolyene compounds from marine dinoflagellate Amphidinium sp.; 3) two new series of uncommon steroids from marine in vertebrates.

  • PDF

Biologically active compounds from natural and marine natural organisms with antituberculosis, antimalarial, leishmaniasis, trypanosomiasis, anthelmintic, antibacterial, antifungal, antiprotozoal, and antiviral activities

  • Asif, Mohammad
    • 셀메드
    • /
    • 제6권4호
    • /
    • pp.22.1-22.19
    • /
    • 2016
  • The biologically active compounds derived from different natural organisms such as animals, plants, and microorganisms like algae, fungi, bacteria and merine organisms. These natural compounds possess diverse biological activities like anthelmintic, antibacterial, antifungal, antimalarial, antiprotozoal, antituberculosis, and antiviral activities. These biological active compounds were acted by variety of molecular targets and thus may potentially contribute to several pharmacological classes. The synthesis of natural products and their analogues provides effect of structural modifications on the parent compounds which may be useful in the discovery of potential new drug molecules with different biological activities. Natural organisms have developed complex chemical defense systems by repelling or killing predators, such as insects, microorganisms, animals etc. These defense systems have the ability to produce large numbers of diverse compounds which can be used as new drugs. Thus, research on natural products for novel therapeutic agents with broad spectrum activities and will continue to provide important new drug molecules.

F9 기형암종 세포에 대한 해양천연물질의 분화 유도 작용 (Differentiation Effect of Marine Natural Compounds on F9 Teratocarcinoma Stem Cells)

  • 김리라;백진현;조용진;손병화;최홍대;김규원
    • 약학회지
    • /
    • 제40권6호
    • /
    • pp.690-696
    • /
    • 1996
  • It has been known that many kinds of cancer are caused by continued proliferation or abnormal differentiation. Thus, recent approaches to anticancer therapy have been focused on developing drugs that induce differentiation of cancer cells to normal cells. A typical differentiation agent, all trans-retinoic acid, is unsuitable for anticancer drug because all trans-retinoic acid produces unfavorable side effects and cytotoxicity in normal cells. Therefore, we have screened some new differentiation-inducing compounds obtained from marine organisms using F9 teratocarcinoma stem cells as a model system. We observed that fatty acid. glycolipid, saponin, sphingosine and sterol compounds of marine organisms had differentiation-inducing activity in F9 cells, were determined by morphological changes and Northern blot analysis. The expression of differentiation marker genes, such as laminin B1, type IV collagen and retinoic acid receptor beta were induced by treatment with those compounds.

  • PDF

Two New Scalaranes from a Korean Marine Sponge Spongia sp.

  • Yang, Inho;Nam, Sang-Jip;Kang, Heonjoong
    • Natural Product Sciences
    • /
    • 제21권4호
    • /
    • pp.289-292
    • /
    • 2015
  • Intensive chemical investigation of Korean marine sponge Spongia sp. has led to the isolation of two new scalaranes. The planar structures of the new compounds 1 and 2 were determined through 1D and 2D NMR spectral data analysis, while the relative stereochemistry of the compounds was determined based on the analysis of $^1H-^1H$ coupling constants and NOESY spectroscopic data. Compounds 1 and 2 did not display any significant biological activities on farnesoid X-activated receptor (FXR) in co-transfection assay.